Praxis der Früherkennung des Prostatakarzinoms
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://link.springer.com/article/10.1007/s00120-018-0644-0/fulltext.html
Reference8 articles.
1. Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF (2015) Leitlinienprogramm Onkologie: Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Langversion 4.0. Urologe. https://doi.org/10.1007/s00120-015-3843-y
2. Hayes JH, Barry MJ (2014) Screening for prostate cancer with the prostate-specific antigen test. JAMA 311:1143. https://doi.org/10.1001/jama.2014.2085
3. Ilic D, Mm N, Djulbegovic M, Dahm P (2013) Screening for prostate cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004720.pub3 (Review)
4. Schröder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328. https://doi.org/10.1056/NEJMoa0810084
5. Schröder FH, Hugosson J, Roobol MJ et al (2014) Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 384:2027–2035. https://doi.org/10.1016/S0140-6736(14)60525-0
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PSA screening for prostate cancer in the United States: 30 years of controversy;Journal of Public Health Policy;2024-08-02
2. Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe;European Urology;2024-05
3. Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium;Journal of Personalized Medicine;2024-01-11
4. Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit;BMJ;2023-05-17
5. Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial;Scientific Reports;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3